Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines

mRNA represents a promising new vaccine technology platform with high flexibility in regard to development and production. Here, we demonstrate that vaccines based on sequence optimized, chemically unmodified mRNA formulated in optimized lipid nanoparticles (LNPs) are highly immunogenic and well tol...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutz, Johannes, Lazzaro, Sandra, Habbeddine, Mohamed, Schmidt, Kim Ellen, Baumhof, Patrick, Mui, Barbara L., Tam, Ying K., Madden, Thomas D., Hope, Michael J., Heidenreich, Regina, Fotin-Mleczek, Mariola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648897/
https://www.ncbi.nlm.nih.gov/pubmed/29263884
http://dx.doi.org/10.1038/s41541-017-0032-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648897/
https://www.ncbi.nlm.nih.gov/pubmed/29263884
http://dx.doi.org/10.1038/s41541-017-0032-6

Ejemplares similares